Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Medicine"
DOI: 10.1002/cam4.1104
Abstract: The use of neoadjuvant chemotherapy or radiation for borderline resectable pancreatic adenocarcinoma (BL‐PDAC) is increasing. However, the impact of neoadjuvant chemotherapy and radiation therapy on the outcome of BL‐PDAC remains to be elucidated. We performed… read more here.
Keywords: chemotherapy; upfront chemotherapy; received upfront; neoadjuvant chemotherapy ... See more keywords
Impact of Upfront Chemotherapy on Overall Survival in Isolated Myeloid Sarcoma
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-123308
Abstract: Introduction Myeloid sarcoma (MS) is a tumor composed of myeloid blasts occurring at a site other than the bone marrow. MS may precede or coincide with acute myeloid leukemia (AML) or may also be an… read more here.
Keywords: chemotherapy; myeloid sarcoma; upfront chemotherapy; treatment ... See more keywords
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-019-08023-1
Abstract: Introduction Chemotherapy is increasingly administered prior to resection in patients with early-stage pancreatic adenocarcinoma, but the national prevalence of this practice is poorly understood. Our objectives were to (1) describe the utilization of upfront chemotherapy… read more here.
Keywords: chemotherapy; upfront chemotherapy; stage pancreatic; subsequent resection ... See more keywords